|
Comparison
|
p-value
|
|---|
| |
sST2
|
BNP
|
hs-CRP
|
|---|
|
A vs B
|
0,514
|
0,628
|
0,872
|
|
A vs C
|
0,007
|
0,213
|
0,004
|
|
A vs D
|
<0,001
|
0,207
|
0,017
|
|
B vs C
|
0,121
|
0,863
|
0,041
|
|
B vs D
|
<0,001
|
0,504
|
0,048
|
|
C vs D
|
0,001
|
0,091
|
0,659
|
|
Overall
|
<0,001
|
0,301
|
0,039
|
- Soluble ST2 was significantly different between group A (healthy controls) and patients with type 2 diabetes without (group C) LVDD (p = 0.007). Moreover, patients with type 2 diabetes with LVDD (group D) had the highest mean serum level of sST2 compared to the correspondent of the rest 3 subject groups: group A (p < 0.001), group B (p < 0.001) and group C (p = 0.001). The respective mean values of BNP for the 4 study groups could not achieve statistical difference. All subjects with type 2 diabetes presented higher hs-CRP levels compared to the non-diabetic population of the study.
